Parkinson’s Disease (PD) is a degenerative disorder of the central nervous system that affects close to one million Americans. PD is a chronic and progressive disorder, which is thought to be caused by the destruction of dopamine (an important neurotransmitter) that generates cells in the midbrain. The cause of PD is unknown and there is no cure. Treatment is focused on medication and management of symptoms. Current research include investigations into new animal models of the disease, and of the potential use of gene therapy, stem cell transplants and neuro-protective agents. There is hope that mesenchymal stem cells will mitigate some of the degenerative effects.
The Cell Surgical Network (CSN) has developed a specific deployment protocol that attempts to utilize the regenerative properties of stromal vascular fraction (SVF), which is rich in mesenchymal stem cells and growth factors. Special measures are taken to optimize transport of SVF across the blood-brain barrier to improve central nervous system uptake. This is completed in an outpatient setting at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.
The Cell Surgical Network takes pride in the time provided to patients to follow the more currently updated protocols to help patients achieve their goals. By filling out our Confidential Candidate Application, we can then answer the questions or concerns you may have about our existing procedures for Parkinson’s Disease.